Prospective surveillance reveals high rates of antimicrobial resistance in urinary tract infections among patients with cirrhosis.

The study highlights alarming antimicrobial resistance, particularly in nosocomial UTIs. Traditional antibiotics, such as ceftriaxone for community-acquired UTIs and carbapenems or piperacillin/tazobactam for nosocomial infections, fail to provide sufficient empirical coverage. More comprehensive approaches to empirical treatment, such as combination therapies or newer antibiotics targeting resistant pathogens, are needed.

Authors

Institutions

Publication Details

Journal
Annals of Hepatology
Published
2025-10-09
DOI
https://doi.org/10.1016/j.aohep.2025.102135
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospective surveillance reveals high rates of antimicrobial resistance in urinary tract infections among patients with cirrhosis.

Josefina Pagés, Maximiliano Gabriel Castro, Antonio Santo, Melisa Dirchwolf et al.
Annals of Hepatology
Liver Disease and Transplantation
article

Prospective surveillance reveals high rates of antimicrobial resistance in urinary tract infections among patients with cirrhosis.

Josefina Pagés, Maximiliano Gabriel Castro, Antonio Santo, Melisa Dirchwolf, Adrian Carlos Gadano, Astrid Smud, Alina Zerega, Jesica Tomatis, Lorena Notari, Manuel Mendizábal, María Dolores Murga, Gonzalo Gómez Perdiguero, Pablo Calzetta, Gisela Gualano, María Laura Garrido, Sebastián Marciano, Margarita Anders, Diego Hernan Giunta, Fernando Cairo, Julia Brutti, Carolina Vázquez, Anabel Romero, Esteban González Ballerga, Martín Elizondo, Ana Palazzo, Diego Arufe, Brenda Osso Sánchez, Natalie Vilcinskas, Camila Maria Briz, Ilse Sorena Pardo Ivirico
article en

Abstract

The study highlights alarming antimicrobial resistance, particularly in nosocomial UTIs. Traditional antibiotics, such as ceftriaxone for community-acquired UTIs and carbapenems or piperacillin/tazobactam for nosocomial infections, fail to provide sufficient empirical coverage. More comprehensive approaches to empirical treatment, such as combination therapies or newer antibiotics targeting resistant pathogens, are needed.

Annals of HepatologyVol. 31(1)
University of Mendoza (AR), National University of Tucumán (AR), Hospital Italiano de Buenos Aires (AR), National University of Santiago del Estero (AR), Centro Científico Tecnológico - Santa Fe (AR), Hospital Quirónsalud Sagrado Corazón (ES), Hospital Fernández (AR), Hospital Universitario Austral (AR), Centro Científico Tecnológico - San Luis (AR), Hospital de Clínicas "José de San Martín" (AR), Instituto Universitario de la Policía Federal Argentina (AR), Hospital Alemán (AR), Hospital Central de las Fuerzas Armadas (UY), Hospital El Cruce (AR), Hospital Privado (AR), Fundacion Allende (AR)
Openalex Percentile: Top 62%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.